ACRIVON THERAPEUTICS INC (ACRV)
US0048901096 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 3,747.25% | N/A 486.34% | N/A 68.74% | N/A 96.91% | N/A 44.42% | N/A -14.71% | |||||
| EBITDA YoY % growth | -3.16M | -16.14M -410.76% | -32.3M -100.12% | -66.567M -106.09% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.17M | -16.18M -410.41% | -32.66M -101.85% | -67.103M -105.46% | N/A -35.07% | N/A -26.55% | N/A -7.64% | N/A 7.74% | N/A 51.45% | N/A 165.78% | N/A 315.95% | N/A 19.21% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.73 60.91% | N/A 5.85% | N/A -11.81% | N/A 1.24% | N/A 2.62% | N/A -6.83% | N/A 86.36% | N/A 726.58% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.68 21.29% | -0.73 -0.66% | -0.77 -47.98% | -0.83 -40.38% | -0.85 -25.06% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -25.357M -20.44% | -24.99M -41.44% | -24.99M -16.57% | -25.5M -1.43% | -25.651M -1.16% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.59 10.61% | -0.59 | 0.00 | -0.13% |
| Q2 2024 Q2Q % growth | -0.52 17.46% | -0.61 | 0.09 | 15.33% |
| Q1 2024 Q2Q % growth | -0.73 -25.86% | -0.86 | 0.13 | 15.28% |
| Q4 2023 Q2Q % growth | -0.86 -7.50% | -0.74 | -0.12 | -15.99% |
| Q3 2023 Q2Q % growth | -0.66 | -0.72 | 0.06 | 8.67% |
| Q2 2023 Q2Q % growth | -0.63 | -0.66 | 0.03 | 4.77% |
| Q1 2023 Q2Q % growth | -0.58 | -0.61 | 0.03 | 5.27% |
| Q4 2022 Q2Q % growth | -0.80 | -1.12 | 0.32 | 28.37% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -10.77% | -10.77% | -3.55% | -3.55% |
| Revenue | N/A | N/A | N/A | N/A |